The abstract is read at the publisher; the summary is JClub's.
In a retrospective single-center cohort of 98 Crohn’s disease patients in Milan, FAMD clustering identified three disease-course trajectory phenotypes, including a small high-burden C3 group (n=11).
- Why it matters: Crohn’s disease varies widely, and baseline features can map to very different treatment and surgical paths. The study tests whether diagnosis-era information can anticipate which trajectory a patient follows.
- What they did: Researchers applied FAMD to 30 baseline and disease-course variables covering demographics, Montreal descriptors, extra-intestinal burden, advanced-therapy exposures, surgery burden, and comorbidity/symptom burden, then clustered in the retained FAMD space. They ranked clusters using a line-weighted therapy score and assessed robustness with silhouette metrics and bootstrap Jaccard stability.
- The result: C3 showed younger diagnosis age, heavier extra-intestinal burden, more intensive and prolonged therapy, greater biologic exposure, and more cumulative surgeries, with comorbidity burden rising across phenotypes. Diagnosis-available variables yielded moderate discrimination for C3 (AUC=0.80, 95% CI 0.67-0.93), improving to AUC=0.90 in a sensitivity analysis.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.